Covance

Clinical Research Associate I

Job Location(s) KR-Seoul
Job Number
2020-52710
Job Category
Clinical Research Associates
Position Type
Full-Time
Telecommute
No

Job Overview

코반스 (Parent company: LabCorp)는 지속적인 성장과 체계적인 시스템 및 업무환경의 Global Top tier CRO로서, 매년 비지니스 확장과 직원수 증가로 현재 전세계 6만명 이상의 직원들이 근무하고 있습니다.
 
코반스 코리아는 Global CRO 중에서도 유일하게 전체 Spectrum, 즉 전 임상부터 Commercial 까지 Full service를 제공할 수 있는 유일한 CRO입니다. 한국은 2005년에 Legal entity 를 설립한 이후 1상부터 4상까지 다양한 indication 의 임상시험을 진행하고 있고, 정확하고 전문적인 성과로 더 크게 성장하고 있으며 직원들에게는 더 많은 커리어 기회를 제공하고 있습니다.
 
We are currently looking for Unblinded CRA to monitor sites in South Korea.
This is a permanent position at Covance - will be dedicated to one sponsor - Global Pharmaceutical company. 
 
This is a fantastic opportunity for someone eager to gain their first monitoring experience. Moreover there is a chance to grow into the CRA role in future. 
 
The Core Responsibilities: 
- Ensure accurate pharmacy documentation is in place
- Ensure investigational medicinal product (IMP) accountability is maintained and blinded and unblinded site staff members can work in a coordinated manner without compromising the blind
- Maintain IMP supplies in suitable storage conditions and ensuring they are accurately reconstituted, dispensed, administered, returned and destroyed
- Maintain all appropriate documentation and ensuring a study drug re-supply procedure will be put in place where necessary
Education/Qualifications: 
- Bachelor's degree in Life Science or preferred in similar qualification
Experience:
- 1-2 years of on-site monitoring experience (full-scope, CRA I) 
- Pharmacy monitoring experience is required
- Preferably in Oncology study experience 

Education/Qualifications

Education/Qualifications: 
- Bachelor's degree in Life Science or preferred in similar qualification

Experience

 
Experience:
- 1-2 years of on-site monitoring experience (full-scope, CRA I) 
- Pharmacy monitoring experience is required
- Preferably in Oncology study experience 

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed